+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Collaboration Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Contract Injectable Packaging Trends in the Bio/Pharma Industry - Product Thumbnail Image

Contract Injectable Packaging Trends in the Bio/Pharma Industry

  • Report
  • August 2022
  • 96 Pages
  • Global
From
Biologic Therapeutic Drugs: Technologies and Global Markets - Product Thumbnail Image

Biologic Therapeutic Drugs: Technologies and Global Markets

  • Report
  • May 2025
  • 170 Pages
  • Global
From
Blood Banking and Blood Products - Global Strategic Business Report - Product Thumbnail Image

Blood Banking and Blood Products - Global Strategic Business Report

  • Report
  • September 2025
  • 357 Pages
  • Global
From
Blood Plasma Products Market in India 2021 - Product Thumbnail Image

Blood Plasma Products Market in India 2021

  • Report
  • March 2021
  • 64 Pages
  • India
Human Immunoglobulin for Intravenous Injection Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Human Immunoglobulin for Intravenous Injection Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 103 Pages
  • Global
From
Primary Immunodeficiency Disorders - Global Strategic Business Report - Product Thumbnail Image

Primary Immunodeficiency Disorders - Global Strategic Business Report

  • Report
  • September 2025
  • 280 Pages
  • Global
From
Chronic Lymphocytic Leukemia- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Lymphocytic Leukemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 46 Pages
  • Global
From
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028 - Product Thumbnail Image

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028

  • Report
  • September 2023
  • 374 Pages
  • Global
From
Plasma Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 194 Pages
  • Global
From
Blood and Blood Components - Global Strategic Business Report - Product Thumbnail Image

Blood and Blood Components - Global Strategic Business Report

  • Report
  • September 2025
  • 370 Pages
  • Global
From
Plasma Fractionation - Global Strategic Business Report - Product Thumbnail Image

Plasma Fractionation - Global Strategic Business Report

  • Report
  • September 2025
  • 245 Pages
  • Global
From
Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report - Product Thumbnail Image

Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report

  • Report
  • September 2025
  • 184 Pages
  • Global
From
Plasma Protein Therapeutics Market Size, Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Plasma-derived Factor VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Plasma Protein Therapeutics Market Size, Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Plasma-derived Factor VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 86 Pages
  • Global
From
Hepatorenal Syndrome Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Hepatorenal Syndrome Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
C1 Esterase Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

C1 Esterase Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Critical Care Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Critical Care Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 280 Pages
  • Global
From
Subcutaneous Immunoglobulin - Global Strategic Business Report - Product Thumbnail Image

Subcutaneous Immunoglobulin - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Loading Indicator